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Idiotypes are antigenic determinants on variable  (V) 1 regions of antibodies. 
Two types of idiotypes have been described. Individual specificities or idiotypes 
(IdI)  unique  to  a  specific antibody  (1-5);  cross-specific  idiotypes  (IdX)  shared 
among immunoglobulins that are usually functionally related (4-10). 
IdI and IdX determinants have been found on human (1-4, 8, 11), rabbit (12-17),  and 
mouse antibodies (5-7, 9-10,  18-28). Antigenic specificities that determine IdI and IdX 
have been localized to V region light chain (VL), V region heavy chain (VH), or to both 
chains  (2,  8,  29-38).  An idiotype can be localized to or near a  complementary region 
when anti-idiotype antibody is blocked by hapten. 
Many IdX have been shown to be genetically controlled (20-28).  In the mouse genes 
controlling al-3 dextran (24), phosphorylcholine (23), phenylazoarsonate (22), and inulin 
(28), cross-specific idiotypes were shown to be linked to the allotype (CH). 
In BALB/c mice a series of 11 myeloma proteins that bind inulin, and bacterial levan 
have been described (10, 28). These proteins all have hapten-binding specificity for a 
series of fl2,1-1inked  fructan oligosaccharides.  Each of the proteins in this group has 
individual antigenic (idiotypic) specificities (IdI) as well as one or more shared idiotypes 
(IdX).  IdI and IdX antisera can be prepared in the homologous species, and hence are 
used in detecting polymorphic differences between strains. 
Genetic analysis  has  shown  that  the  cross-reacting  hapten  inhibitable  idi- 
otypes on the inulin-binding myeloma proteins (InuBMP) are linked to allotype 
(28),  which suggests  that these idiotypes may be useful as markers for genes 
coding for the VH region.  However, their use as such is limited until the light 
chains  are  shown  not  to contribute to the  expression  of the  idiotypes.  If the 
idiotype reflects conformational contribution of both VL and VH, then it reflects 
structures controlled by two different unlinked genes and such genetic studies 
are  precluded  unless  one  uses  strains  which  have  similar  VL repertoires for 
inulin.  In the present study, recombinants of different InuBMP were prepared 
to determine if the idiotypes associated with InuBMP could be localized. 
Materials  and  Methods 
Myeloma  Proteins.  The  BALB/c  IgA  InuBMP  used  in  this  study  have  been  previously 
described and include EPC109  (El09),  Aml (A1), ABPC4  (A4), TEPCS03  (T803), W3082, UPC61 
1  Abbreviations  used  in this paper:  HA, hemagglutination; HI,  hemagglutination inhibition; 
IdI, individual idiotypes; IdX, cross-specific  idiotype; InuBMP, inulin-binding myeloma proteins; 
V, variable; Vm variable region heavy chain; VL, variable region light chain. 
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(U61),  ABPC47N  (A47N),  and  a  new  protein  TEPC957  (T957)  (10).  All  of  these  proteins 
agglutinate beth inulin (~2,1 fructan) and bacterial levan (fl2,1-2,6 fructan) coated SRBC.  The 
InuBMP  were  purified  on  affinity  columns  with  inulin-coupled  Sepharose  4B  (39).  Another 
protein, XRPC24  (X24), used in these studies which binds galactan and not inulin was purified 
on a  bovine serum albumin galactoside column (40). 
Anti-ldiotype Antisera.  Production of anti-idiotype antisera has been described  (10).  A/He 
mice were immunized with each of the InuBMP and the antisera were made specific for inulin 
idiotypes by absorption with a BALB/c IgA non-InuBMP. Anti-IdI antisera were made specific by 
absorbing anti-idiotype antisera with the cross-reactive InuBMP (10). 
Assay  to  Determine  Specificity  of Anti-ldiotype  Antibody.  Antisera  were  tested  in  the 
hemagglutination (HA) and hemagglutination inhibition (HI) systems for idiotypic antibodies as 
previously described (10).  SRBC coated with a  specific InuBMP by the chromic chloride method 
(10)  were tested with anti-idiotype antiserum and the HA titer was determined for each of the 
InuBMP. The antiserum was tested with each of the InuBMP SRBC with which it cross-reacted; 
the InuBMP were then used as inhibitors of this system and the HI titer was determined. 
Titration of Inulin and Levan Antibodies.  Inulin and levan antibody titers were determined 
by HA with SRBC coated with O-stearoyl inulin or levan (28).  Levan was obtained from culture 
supernates ofAerobacter laevanicum  ATCC 15552  (28). 
Separation  and Reeonstitution  of H  and L  Chains of Myeloma  Proteins.  The  method  for 
separating  L  and  H  chains  has  been  described  (41),  and  consisted  of dialyzing  the  purified 
protein against 0.15 M Tris-HC1-0.15 M NaC1-2 mM Na2 EDTA, reduction with 10 mM dithiothre- 
itol, and alkalation with 20 mM iodoacetamide.  The chains were separated on a  G100-6M urea 
Sephadex  column.  Purity  of H  and  L  chain  preparations  was  checked by polyacrylamide  gel 
electrophoresis in 0.1% sodium dodecyl sulfate and contamination was found to be <2%. The H 
and  L  chain  was  recombined  as  described  by  Manjula  et  al.  (42).  Recombinants  from  three 
protein pairs were made: E109-U61, A4-T957, and E109-X24 and put on a  Sephadex G200 column 
to isolate the recombinant monomers (H2L2 tool wt 180,000).  Monomers ofrecombinants of E109H 
+  U61L, E109L +  U61H, A4H +  T957L, A4L +  T957H, E109H +  X24L, and E109L +  X24H were 
obtained with a  yield of 25-90% of the total protein applied to the column.  Dr.  D. J.  Streetkirk 
of the National Cancer Institute, National Institutes of Health kindly determined by fluorescence 
titration, that the binding sites of all the monomers were functional except for E109-X24 which 
did not bind inulin or galactan. 
Results 
Inulin  and  Levan  Activity  of Recombinants  of L  and  H  Chains  of U61, 
E109, A4, and T957 InuBMP.  Monomers of recombinant molecules of U61L 
+  E109H and U61H  +  E109L were tested for HA of SRBC coated with inulin 
and  bacterial  levan  (Table  I).  Both  recombinants  agglutinated inulin-  and 
levan-coated SRBC with titers similar to the U61  and El09 7S molecules. No 
agglutination was obtained with U61 or El09 L and H chains alone. 
Similarly, monomers of recombinants of A4L  +  T957H  and A4H  +  T957L 
agglutinated inulin- and levan-coated RBC while, A4H or A4L alone showed 
no agglutination. When recombinants were made between El09 and X24,  the 
recombinant molecules did not agglutinate inulin- and levan-coated SRBC. 
Localization of Individual Idiotypes of U61, E109, A4, and T957 to Specific 
InuBMP  Immunoglobulin  Chains.  Antisera  specific  for  only the  InuBMP 
used in its preparation identify individual antigenic specificities (IdI)  (Table 
II). Monomers of recombinant molecules of L and H chains from four different 
InuBMP  (U61,  El09,  A4,  and T957) were  used as  inhibitors of anti-IdI sera 
each reacting with SRBC  coated with the homologous protein.  Recombinant 
molecules made with homologous chains (e.g., E109L-E109H) retained their IdI 
(Figs. 1-4).  Dissociated L and H chains did not inhibit IdI antisera. IdI antisera 
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TABLE  I 
Inulin and Levan HA Titers of InuBMP Recombinants and 
Individual L and H Chains 
Myeloma protein  (I mg/ml)  Inulin SRBC  Levan SRBC 
Log 2 HA titer 
U61  15  16 
El09  12  10 
U61L + E109H  10  9 
U61H + E109L  10  8 
U61L  0  0 
U61H  0  0 
E109L  0  0 
E109H  0  0 
E109H + X24L  0  0 
E109L + X24H  0  0 
T957  7  10 
A4  6  12 
A4L + T957H  4  10 
A4H + T957L  4  10 
A4L  0  0 
A4H  0  0 
Recombinants are monomeric (H2L2 mol wt 180,000); U61, El09, T957, 
and A4 are InuBMP; X24 binds galactan but not inulin or levan. 
TABLE  II 
Specificity  of Anti-InuIdI Sera 
Immuno- 
Antiserum  Absorbent 
gen 
Antiserum  Myeloma  InuBMP 
dilution  protein 
SRBC  A4  W3082  T803  U61  El09  A47N  Am1  T957 
HI titer (log 2) 
11142  El09  T803  3,000  El09  0  0  0  0  11  0  0  0 
10570  U61  T803,W3082  200  U61  0  0  0  7  0  0  0  0 
10544  A4  U61,W3082  100  A4  _9  0  0  0  0  0  0  0 
11442  T957  W3082  3,000  T957  0  0  0  0  0  0  0  11 
Underlined numbers indicate titers of lnuIdl. 
expressed  only  when  the  L  chains  of these  four  respective  proteins  were 
present (Figs. 1-4) since the anti-IdI sera for each of  these proteins could only be 
inhibited by molecules containing the appropriate L  chain. 
In the case of A4 IdI some A4H was also required for its expression (Fig.  4). 
The  IdI  of U61,  El09,  and  T957  are  not  inhibitable  by  the  hapten  fructan 
trisaccharide  while  the  A4  IdI  is  associated  with  the  antibody  site  and  is 
hapten inhibitable. 
Localization of Cross-Specific Idiotypes  (IdXB System).  In addition to IdI, 
InuBMP share idiotypes (IdX) with other InuBMP. IdX determinants can also 
be  shared  by  normal  inulin  antibodies  (28).  One  IdX,  IdXB,  specificity  has 
been previously described (10, 28) and was found on U61, W3082, and T803 but 
not  on  El09,  A4,  A47N,  Aml,  and  T957  InuBMP.  Antisera  used  to  identify 
InuIdXB are shown in Table  III. Recombinant molecules U61L  +  E109H and 
U61H +  E109L were used to inhibit the anti-InuIdXB system. Specifically anti- LIEBERMAN,  VRANA,  HUMPHREY,  CHIEN,  AND  POTTER  1297 
Ig CHAIN LOCATION OF E109 Inu  Idl 
Antisera 
SRBC Coated  Fructan  Trisacch.  Inhibitor 
Inhibition  With  0.028 M  H  L 
HI Titer (Log 2) 
0  2  4  6  8  10  12 
Anti-E 109  E109 
Abs. W3082 
NI  E109  E109 
E109  U61  I 
U61  E109 
-  E109  I 
E109  -  I 
E109  X24  I 
X24  E109  I 
FIG. i.  Localization  of  E109 Idl to El09 L chain; also  requires an H chain of  an InuBMP 
to be expressed. Recombinant molecules of L and H  chains of E109, U61 .(InuBMP),  and 
X24, a noninulin-binding  myeloma protein,  were tested  as inhibitors  of  specific  anti-El09 
IdI serum reacted with E109-coated SRBC. E109 IdI is not in the antibody-combining site 
and is not inhibitable (NI)  by fructan trisaccharide.  W3082 is an InuBMP. 
Ig CHAIN LOCATION OF U61 Inu  Idl 
Fructan  Trisacch.  Inhibitor  HI Titer (Log 2) 
SRSC Coated  Inhibition 
Antisera  With  0.028 M  H  L  0  2  4  6  8  10  12 
Anti-U61  U61  NI  U61  U61 
Abs. T803+W3082 
E109  U61 
U61  E109  I 
-  U61  I 
U61  I 
FIG. 2.  Localization of U61 IdI to U61 L chain; also requires an H  chain of  an InuBMP 
to be expressed. Recombinant molecules  of L and H  chains of E109 and U61 (InuBMP) 
were tested  as inhibitors  of  specific  anti-U61 IdI  serum reacted  to  U61-coatod SRBC. U61 Idl 
is  not in the antibody-combining site  and is not inhibitahle  (NI)  by fructan trisaccharide. 
T803 and W3082 are InuBMP. 
T803 (serum  10914)  absorbed  with El09  tested with W3082-coated  SRBC  was 
inhibited by U61 but not El09,  and was also inhibited by U61L  +  E109H but 
not  by  U61H  +  E109L  or by  E109L  and  H  chains  alone  (Fig.  5).  Thus  the 
shared IdXB appears to require the U61 L chain and an InuBMP H chain. 
Localization  of A4  IdXA.  InuIdXA  antiserum  identifies  a  determinant 
shared by many InuBMP including A4, W3082, T803, U61, and El09 but not on 1298  IDIOTYPES  OF  INULIN-BINDING  MYELOMA  PROTEINS 
Ig CHAIN LOCATION OF T957 Inu Idl 
Antisera 
Fructan  Trisacch.  Inhibitor  SRBC Coated  Inhibition  With  0.028 M  H  L  0  2 
HI Titer (Log 2) 
4  6  8  10  12 
Anti-T957  T957 
Abs. W3082+A4 
NI  T957  T957  I 
A4  A4  I 
T957  A4  I 
A4  T957 
A4  -  I 
-  A4  I 
W3082  W3082  I 
FIG.  3.  Localization of T957 IdI to T957 L chain; also requires an H chain of an InuBMP 
to be expressed.  Recombinant molecules of L and H  chains of T957 and A4 InuBMP were 
tested as inhibitors of specific anti-T957 serum reacted with T957-coated SRBC. T957 IdI is 
not in the  antibody-combining  site  and is not inhibitable  (NI) by fructan trisaccharide. 
W3082 is an InuBMP. 
Ig CHAIN LOCATION OF A4 Inu  tdl 
Fructan Trisacch.  Inhibitor  HI  Titer (Log 2)  SRBC Coated  Antisera  Inhibition 
With  0.028 M  H  L  0  2  4  6  8  10  12 
Anti-A4  A4  0.0035 
abs. U61 + W3082 
A4  A4 
T957  T957  I 
1"957  A4  • 
A4  T957  • 
A.  | 
--  A4  I 
U61  U61  | 
W3082  W3082  I 
FIG.  4.  Localization of A4 IdI primarily to  A4 L  chain; also requires  an H  chain of an 
InuBMP  to  be  expressed.  Recombinant  molecules  of  L  and  H  chains  of A4  and  T957 
InuBMP  were  tested  as  inhibitors  of  specific  anti-A4  serum  reacted  with  A4-coated 
SRBC.  A4 IdI  is  associated with the antibody  site  and is hapten  (fructan trisaccharide) 
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TABLE III 
Specificity  of Anti-InuldXB Serum 
1299 
Antiserum 
Antiserum  Myeloma  Myeloma proteins  (1 mg/ml) 
[mmunogen  dilution  proteins on 
SRBC  U61  E109  A4  W8082  T803  A47N  Am1  '1"957 
Log 2  HI titer 
10914 Abs E109  T803  4,000  W3082  10  O  0  >8  7  0  0  0 
10570  "  U61  4,000  W3082  8  _0  0  >8  >8  0  0  0 
10789  "  W3082  3,000  U61  10  O  0  >8  >8  0  0  0 
10909  "  T803  1,000  T803  _9  0  0  >8  >8  0  0  0 
InuldXB is a crom~specific idiotype designated B found on U61, W3082, and T803 myeloma proteins (10). 
I  0 CHAIN LOCATION OF U61 Inu IdXB 
Antisera 
Fructan Trisacch.  Inhibitor  HI Titer (Log 2) 
SRBC Coated  Inhibition 
With  0.028 M  H  L  0  2  4  6  8  10  12 
Anti-TS03  W3082  0.00087 
Abs. E109 
U61  U61 
E109  E109  I 
W3082  W3082 
U61  E109  I 
E109  U61 
E109  -  I 
U61  -  I 
E109  I 
-  U61  I 
X24  E109  I 
E109  X24  I 
FIG. 5.  Localization  of  IdXB to  U61 L chain;  also  requires  an H chain  of  an InuBMP to 
be  expressed.  IdXB is  shared  by  U61,  T803,  and  W3082 InuBMP and  is  inhibitable  by  the 
hapten,  fructan  trisaccharide.  Recombinant  molecules  of  L and H chains  of  U61 and E109 
were  tested  as  inhibitors  of  a  specific  anti-IdXB  serum reacted  to  W3082-coated  SRBC. 
T957, Aml, or A47N  (I0,  28).  Antisera identifying the InuIdXA system are 
shown on Table IV. In addition antisera identifying another specificity  (not 
previously described) designated InuldXA' showed the same pattern of  cross- 
reactions as InuldXA except that it also  cross-reacted with A47N  (Table IV). 
Recombinant molecules A4H + T957L and A4L + T957H were used  as  inhibitors 
of the anti-IdXA and anti-ldXA'.  Anti-El09 serum absorbed with T957 and 
tested with A4-coated SRBC  was inhibited by A4 but not T957, and was also 
inhibited by A4H  +  T957L but not by A4L + T957H nor A4L or A4H  chains 
alone (Fig.  6). The IdXA determinant was associated with the A4H chain but 
required an InuBMP  L chain. 1300  IDIOTYPES  OF  INULIN-BINDING  MYELOMA  PROTEINS 
TABLE  IV 
Specificity of Anti InuIdXA Serum 
SRBC 
lmmuno-  Antiserum  InuIdX 
Antiserum  coated  A4  T957  W3082  T803  U61  E109  A47N  Aml 
gen  dilution  with:  identified 
11142  Abe T957  El09  5,000  A4  A'  12  0  >8  8  8  >8  10  0 
11142  "  E109  5,000  A47N  A'  9  0  >8  8  8  >8  10  0 
11142  "  E109  5,000  U61  A'  _7  O  >8  8  8  >8  10  0 
10789  "  W3082  100  A4  A  8  O  >8  8  8  4  0  0 
11171  "  A47N  400  A4  A'  7  O  >8  8  8  >8  8  0 
10544  "  A4  400  U61  A  9  0  >8  8  8  >8  0  O 
10544  "  A4  1,000  A47N  A  1_33  _0  >8  8  8  >8  0  0 
InuIdXA is  an inulin  cross-specific  idiotype  found on A4, W3082, T803, U61, and El09. A new InuIdXA-like  cress  idiotype  (A')  is  similar 
to InuIdX except that it  is  also  present on A47N. 
Ig CHAIN  LOCATION OF A4 Inu IdXA 
Fructan  Trisacch.  Inhibitor 
Antlsera  SRBC Coated  Inhibition 
With  0.028 M  H  L  0  K 
HI Titer (Log 2) 
2  4  6  8  10  12 
Anti-El09  A4  0.0087  A4  A4 
Abs. T957 
T957  T957  I 
A4  T957 
T957  A4  I 
A4  -  I 
-  A4  I 
X24  E109  I 
E109  X24  I 
FIG. 6.  Localization  of  IdXA to A4 H chain; also  requires an L chain of  an InuBMP to be 
expressed. IdXA is  found on  A4, W3082, T803, U61, E109, and A47N InuBMP. Recombinant 
molecules of L and H  chains of A4 and T957 were tested as inhibitors  of a specific  anti- 
IdXA serum reacted to E109-coated SRBC. 
Discussion 
The topography of  six idiotypes  associated  with InuBMP were studied. The 
U61, E109, T957, and A4-Idl and IdXB of  U61 were determined by the V  L, but 
only when the V  L  was bound to a VH domain from another InuBMP. The IdXA 
on A4 was determined by the Vm  but only when the VH Was bound to the 
appropriate VL domain.  Apparently  a specific  VHVL pair is needed for the 
expression of these idiotypes because the dissociated VL and VH failed to 
exhibit the idiotypes.  Though five  of  these idiotypes  are determined by the L 
chain one cannot discern  whether a part of  the idiotype  is contributed by the H 
chain or if  the idiotypes  are exclusively  on the L chain. In regard to the latter 
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conformation such that the  L  chain  idiotype can be expressed.  Whatever the 
role of the H  chain is in idiotypic expression,  it is likely that the VH from an 
InuBMP  is  necessary  since  the  H  chain  from  a  galactan-binding  myeloma 
protein  (X24)  combined  with  E109L  chain  didn't  result  in  expression  of any 
El09 idiotypes. 
There  have been many  idiotypes linked to allotype reported in the  mouse, 
including the IdXB idiotype associated with U61L discussed in this paper (22- 
24,  28).  It is often assumed that these idiotypes are markers for genes coding 
for the VH region since there is linkage of VH to CH (22-28, 43). The contribution 
of the L chain to expression of these idiotypes must be understood before these 
markers  can  be  used  in  genetic  studies.  For  example  in  previous  genetic 
studies (28) it was presumed that InuIdXB was a  VH marker since it appeared 
to  be  associated  with  the  BALB/c  CH  allotype.  In  these  studies  backcross 
progeny of BALB/c (IdXB  +) ×  C57BL (IdXB-)F1  x  C57BL showed that the 50% 
of the progeny which carried the BALB/c allotype were IdXB  + while the 50% 
lacking the BALB/c allotype were IdXB-. However, linkage of IdXB to allotype 
is  difficult  to  understand  since  the  findings  in  this  paper  show  that  the 
InuIdXB  idiotype is  determined  by L  chain  differences questions  the  former 
assumption  that  InuIdXB  is  a  VH  marker,  but  shows  instead  that  it  is  a 
marker for a  specific VH-VL pair which depends on the structure  of VL for its 
expression. Thus the backcross data may indicate:  (a) that there is no polymor- 
phism  of the  L  chain  and  the  VL of BALB/c  and  C57BL  are  the  same  but 
require  the  appropriate  Vs  (BALB/c)  to  be  expressed?  or  (b)  that  there  is 
indeed  polymorphism  of the  L  chains  but  selection  among  the  L  chains  of 
C57BL for the appropriate  L chain to pair with the VH of BALB/c is regulated 
by the H  chain of BALB/c? 
Congenic strain data (28) permits further analysis of idiotype genetics. CB20 
presumably  has  the  L  chains  of BALB/c and  the  H  chain  of C57BL  and  is 
IdXB-, indicating that it has the wrong VH for the VH-V~. pair that determines 
IdXB.  BAB14 on the  other  hand  is  identical  to CB20 except that  at the  14th 
generation when a separate line was established a crossover occurred in the VH 
region so that VL and VH markers are of the BALB/c type and the CH is of the 
C57BL type. This strain is IdXB  +, showing expression of the appropriate VL-VH 
pairs. 
The more provocative finding is in the BC-8 congenic strain which presumably 
has  the  C57BL L  chain  and  BALB/c H  chain.  These  mice are  IdXB  +,  which 
suggests:  (a) that the L chain of C57BL and BALB/c are the same and either 
one uses the Vu of BALB/c to express IdXB or (b) that there is regulation of 
the  C57BL  L  chain  by the  H  chain  of BALB/c which  selects  among  the  L 
chains,  for the appropriate one, permitting expression of IdXB. 
IdXB can be used as both a  H  and L chain marker as long as proper strain 
combinations are used. The idiotype is potentially useful as a  L chain marker 
so  long  as  both  parental  strains  have  the  same  or  permissive  VH  genes. 
Specifically,  the  VH in  BALB/c and  RIII  appear  to  be  very similar  because 
IdXA and IdXG are present in both while the IdXB is lacking in RIII (28). 
Conversely, to study the genetic differences of a  VH, it must first be shown 
that the strains compared have similar VL. Idiotypes linked to allotypes should 1302  IDIOTYPES  OF  INULIN-BINDING  MYELOMA  PROTEINS 
not be considered VH markers until it is demonstrated that the L chains in the 
strains involved are not polymorphic. 
Summary 
Idiotypes of inulin-binding myeloma proteins  (InuBMP)  were  determined 
primarily by  variable  region  light chains  (VL) or  by variable  region  heavy 
chains  (VH) but needed both chains to be expressed.  Recombinant molecules 
were used to show that individual idiotypes (IdI) of U61,  EI09, T957,  and A4 
InuBMP and cross-specific idiotypes (IdXB) of U61 were primarily determined 
by V  L while cross-specific idiotype (IdXA) of A4 was determined mainly by VH. 
The assignment of genes controlling idiotypes to VH based on allotype linkage 
(e.g.,  IdXB)  is  dubious  until  the  role  of the  L  chain  in  determining that 
idiotype  is  assessed.  IdXB  has  been  shown  to  be  a  VL-V  H  marker  which 
presumably is controlled by two unlinked genes. However IdXB can be used as 
a  L chain marker in combinations of strains differing in their L chain genes 
but having the same permissive H chain genes. Conversely IdXB can be used 
as a  H chain marker in strains having the same permissive L chain genes but 
differing in their H chain genes. 
Received for publication 30 June 1977. 
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